Šīs tīmekļa vietnes satura kvalitātes uzlabošanai un pielāgošanai lietotāju vajadzībām tiek lietotas sīkdatnes - tai skaitā arī trešo pušu sīkdatnes. Turpinot lietot šo vietni Jūs piekrītat sīkdatņu lietošanai.
About acquisition of significant shareholding
Emitents Olainfarm, AS (213800WCG52W62ENOP27)
Veids 2.3. Paziņojumi par būtisku akciju paketi
Valoda EN
Statuss Publicēts
Versija
Datums 2018-10-05 16:48:19
Versijas komentārs
Teksts

On October 5, 2018 JSC Olainfarm has received a notification from shareholder Irina Maligina on increased material shareholding up till 7.79% from share capital with voting rights, since the 25th of September, 2018.

The announcement of I. Maligina attached.

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top- quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 60 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:

Dana Hasana
Head of PR
JSC Olainfarm
Phone +371 26355895
Email: dhasana@olainfarm.lv

 

 

 

Pielikumi
I.Maliginas_Pazinojums_par_nozimigu_lidzdalibu.pdf (319.76 kB)